Treatment Against Mutation of PIK3CA Gene Involved in Lung Cancer by Structure Base Pharmacophore Modeling, Virtual Screening and Molecular Docking

Advances in Pharmacology and Pharmacy
doi 10.13189/app.2019.070403
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Horizon Research Publishing Co., Ltd.

Related search

Identification of Novel Acetylcholinesterase Inhibitors Designed by Pharmacophore-Based Virtual Screening, Molecular Docking and Bioassay

Scientific Reports
Multidisciplinary
2018English

In Silico Studies on Novel Inhibitors of MERS-CoV: Structure-Based Pharmacophore Modeling, Database Screening and Molecular Docking

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2018English

Structure-Based Virtual Screening and Molecular Docking for the Identification of Potential Multi-Targeted Inhibitors Against Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2017English

Potent Bace-1 Inhibitor Design Using Pharmacophore Modeling, in Silico Screening and Molecular Docking Studies

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2011English

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2017English

Insight Into the Structure of Tetramer hTRPV1 From Homology Modeling, Molecular Docking, Molecular Dynamics Simulation and Virtual Screening

Biophysical Journal
Biophysics
2015English

Virtual Screening Using Structure-Based Consensus Pharmacophore Models and Ensemble Docking Based on MD-generated Conformations

Journal of Cheminformatics
Computer GraphicsInformation SciencesLibraryTheoretical ChemistryComputer Science ApplicationsComputer-Aided DesignPhysical
2011English

PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

A Combination of Pharmacophore Modeling, Molecular Docking and Virtual Screening Study Reveals 3,5,7-Trihydroxy-2-(3,4,5-Trihydroxyphenyl)- 4h-Chromen-4-One as a Potential Anti-Cancer Agent of COT Kinase

Indian Journal of Pharmaceutical Education and Research
ToxicologyPharmaceuticsPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy